FDA Inspection 1325066 — Bloodworks
The FDA completed an inspection of Bloodworks on Jun 30, 2026 in Bellingham, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 30, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Bellingham, WA (United States)